SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-046970
Filing Date
2020-08-17
Accepted
2020-08-17 16:54:32
Documents
2
Period of Report
2020-08-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3450
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 2443
  Complete submission text file 0001209191-20-046970.txt   7219
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address
Von Seggern Christopher (Reporting) CIK: 0001821192 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36687 | Film No.: 201110907